Brief: Oxigene appoints Matthew M. Loar as CFO
20/07/2015 21:00
July 20 (Reuters) - OXiGENE Inc OXGN.O : * Appoints Matthew M. Loar as chief financial officer * Says Loar most recently was chief financial officer at Kinemed, Inc * Source text for Eikon ID:nGNXVEAJUa * Further company coverage OXGN.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas